Front. Microbiol. Frontiers in Microbiology Front. Microbiol. 1664-302X Frontiers Media S.A. 10.3389/fmicb.2016.01464 Microbiology Correction Corrigendum: Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus Ou Changbo 1 † Zhang Qiang 2 † Wang Juan 3 Wu Guojiang 4 Shi Ningning 5 He Cheng 2 * Gao Zengping 3 * 1College of Animal Science, Henan Institute of Science and Technology Xinxiang, China 2Key Lab of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University Beijing, China 3School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing, China 4College of Life Science, Agricultural University of Hebei Baoding, China 5College of Pharmacy, Hebei Medical University Shijiazhuang, China

Edited and reviewed by: Luis Cláudio Nascimento Da Silva, CEUMA University, Brazil

*Correspondence: Cheng He hecheng@cau.edu.cn

Zengping Gao gaozengping0812@163.com

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

†These authors have contributed equally to this work.

 15 09 2016 2016 7 1464 20 08 2016 01 09 2016 Copyright © 2016 Ou, Zhang, Wang, Wu, Shi, He and Gao. 2016 Ou, Zhang, Wang, Wu, Shi, He and Gao

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus by Ou, C., Zhang, Q., Wu, G. J., Shi, N., and He, C. (2015). Front. Microbiol. 6:592. doi: 10.3389/fmicb.2015.00592 dryocrassin ABBA influenza virus H5N1 phloroglucinol compound antiviral activity Rhizoma Dryopteridis Crassirhizomatis amantadine

In the original research article, Juan Wang and Zengping Gao were not included in the author list. They have now been included along with the affiliation: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

In addition, Zengping Gao has been included as a corresponding author.

Finally, the authors unintentionally did not acknowledge funding from the National Natural Science Foundation of China No.31270400.

The authors apologize for these oversights. These errors do not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.